Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • Eleven Minutes
    • Priced Out
    • Data Grab
    • Memory Gaps
    • Growing Up Scared
    • Denied
    • Opioid Settlement Tracking
    • Guns, Race, and Profit
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email
  • Add Us to Google

Friday, Nov 13 2026

Full Issue

In Major Shift, Older Men With Average Risk Of Prostate Cancer Urged To Get Screened Every 2 Years

The updated guidelines from the American Cancer Society are targeted at men between the ages of 50 and 69. Moreover, Black men and those at higher risk for prostate cancer should get an annual prostate-specific antigen test starting at 45, the group recommended. The U.S. Preventive Service Task Force still recommends against routine PSA screening, advising that men should make the decision to test in consultation with their doctor.

Stat: Prostate Screening Guidelines Updated By American Cancer Society 

In a major change to screening guidelines, the American Cancer Society recommended on Thursday that American men between ages 50 and 69 at an average risk of prostate cancer should test their prostate-specific antigen (PSA) blood levels every two years. The prior guidelines, released in 2010, left testing for average-risk men to their discretion, after assessing cancer risk with a physician. (Merelli, 11/12)

More news about cancer —

The Hill: Joe Biden Says He Didn't Hide Cancer Diagnosis While President

Former President Biden said in an interview published Wednesday he did not hide his aggressive stage 4 prostate cancer diagnosis while he was in the White House, adding he would not have sought a second term had he been diagnosed early. People magazine released an interview with the 46th president ahead of the release of his upcoming memoir, “Promise Me, America,” set to be published by Hachette Book Group on Nov. 17. The outlet asked Biden about what he described as the public’s “cynical twist” of his diagnosis — referring to how some people accused him of hiding his illness while in office. (Mancini, 11/11)

Los Angeles Times: Cancer Institute Backed By Larry Ellison Plans Major Layoffs In Los Angeles 

The Ellison Medical Institute — a cancer research center funded by tech mogul Larry Ellison — will cut a chunk of its staff in a couple of months. The Los Angeles-based research center, led by its founding chief executive and oncologist, David Agus, plans to permanently lay off 88 employees in January, according to a Worker Adjustment and Retraining Notification filed Nov. 4. (Chakarian, 11/12)

ScienceDaily: Scientists Discover A Common Sugar May Help Cancer Cells Break Free And Spread 

Scientists have uncovered a surprising way that fructose, a sugar commonly found in sweetened foods and drinks, may help aggressive ovarian cancer spread. Researchers discovered that cancer cells surviving chemotherapy release fructose that weakens the bonds holding neighboring tumor cells together, making it easier for cancer to spread. High dietary fructose levels and cholesterol-lowering statins also produced concerning effects in preclinical experiments. (11/11)

Newsweek: Ovarian Cancer Is Often Found Late—Scientists Uncover Hidden Early Warning

Researchers have found a way to detect an early warning sign of advanced ovarian cancer which is typically invisible to normal imaging methods. Experts at Hoag Memorial Hospital Presbyterian found that one blood marker could help clinicians identify whether a patient has serous tubal intraepithelial carcinoma, a microscopic, non-invasive lesion that develops in the lining of the fallopian tube, which is an early sign of high-grade serous ovarian cancer. (Laws, 11/12)

News-Medical: New Surgical Approaches Aim To Improve Stomach Cancer Outcomes

Sometimes innovation in cancer care means developing something entirely new. Other times, it means returning to an old idea with the knowledge and tools to make it work better. (11/12)

The Washington Post: Breast Cancer Treatment Can Weaken Bones. Here’s How To Protect Them 

A recent systematic review and meta-analysis published in Frontiers in Oncology found that breast cancer patients were more likely to develop osteoporosis or break a bone than those who hadn’t. (Felton, 11/13)

Also —

KCCI: Iowa Young Adult Cancer Rates Rise, Registry Says

More Iowa young adults are getting a cancer diagnosis. This year, the Hawkeye State was named No. 2 in the country for those aged 20 to 39 getting the disease. (Behnke, 11/12)

Iowa Public Radio: UI Study Finds Pesticides In Water, Leaves And Indoor Dust

A University of Iowa study provides new insights into the ways pesticides move through Iowa’s environment. The researchers detected common farm chemicals in samples from streams and rivers in northeast Iowa. They also found pesticides in leaves from Iowa City and indoor dust from homes across the state. A growing body of research suggests exposure to certain pesticides increases risks for adverse health outcomes, including cancer, neurological disorders and hormone disruptions. (Cramer, 11/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, November 13
  • Thursday, November 12
  • Tuesday, November 10
  • Friday, November 6
  • Thursday, November 5
  • Wednesday, November 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF